Skip to content
Back to Guavy Wire
Stocks

Amgen Data Breach Exposes Patient Health Information

Instruments
AMGN
Share

Edelson Lechtzin LLP, a law firm, has launched an investigation into a data breach at Amgen that exposed patient health information. The data breach occurred in August 2026 and affected unknown individuals. Edelson Lechtzin LLP is investigating the incident to determine the extent of the exposure and whether any legal action is necessary.

No further details on the number of patients affected or the type of information exposed are available. Amgen has not commented on the data breach or the investigation. The law firm encourages anyone who may have been affected by the data breach to contact them for more information.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc